An Open labelled Non Randomised Parallel group clinical controlled trial on Saraswata Ghrita ( oral) and Chaturbhadra Kalpa Basti in the management of Global developmental delay (GDD) in Children

Global Developmental delay ( GDD ) is one of the most steadily rising complex neuromuscular developmental disorder in past few decades, but there is no certain treatment available in any modalities. Ayurveda is the ray of hope for such kind of  clinical conditions.Therefore, I select this trial. Clinical trial will be done on two group A and B . In group A Saraswata ghrita using route of administration as Paan (Oral route) for 84 day’s without any gap and In Group B Chaturbhadra Kalp Basti (Per rectal route) ,12 day schedule ( 4 sneha vasti in beginning, 4 niruh vasti in mid, 4 sneha vasti in last ). Minimum 30 GDD  diagnosed children, aged 1 to 5 years clinically studies of treatment modules. Each segment of treatment module will be  for 84 day’s. After, each treatment there is a gap of 24  days in group  B, Total duration of trial is 84 days. A follow up will be done after 30 days of complete clinical trial.